Lazard Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Lazard Asset Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-183,991	Closed	-$2.51M	–	2323
2024 Q1	$2.51M	Hold	183,991	–	–	﹤0.01%	802
2023 Q4	$2.48M	Hold	183,991	–	–	﹤0.01%	811
2023 Q3	$2.29M	Sell	183,991 -1,341	-0.7%	-$17.6K	﹤0.01%	850
2023 Q2	$2.51M	Hold	185,332	–	–	﹤0.01%	847
2023 Q1	$2.58M	Hold	185,332	–	–	﹤0.01%	868
2022 Q4	$2.63M	Hold	185,332	–	–	﹤0.01%	861
2022 Q3	$2.53M	Hold	185,332	–	–	﹤0.01%	835
2022 Q2	$2.64M	Hold	185,332	–	–	﹤0.01%	853
2022 Q1	$3.06M	Hold	185,332	–	–	﹤0.01%	828
2021 Q4	$3.56M	Hold	185,332	–	–	﹤0.01%	838
2021 Q3	$3.85M	Sell	185,332 -19,130	-9%	-$409K	﹤0.01%	813
2021 Q2	$4.38M	Hold	204,462	–	–	﹤0.01%	741
2021 Q1	$4.03M	Hold	204,462	–	–	﹤0.01%	698
2020 Q4	$4.04M	Hold	204,462	–	–	0.01%	684
2020 Q3	$3.59M	Buy	204,462 +11,892	+6%	+$213K	0.01%	651
2020 Q2	$3.46M	Buy	192,570 +148,525	+337%	+$2.55M	0.01%	615
2020 Q1	$659K	Buy	+44,045	New	+$721K	﹤0.01%	781
2014 Q1	–	Sell	-149,729	Closed	-$3.06M	–	1034
2013 Q4	$3.06M	Hold	149,729	–	–	0.01%	573
2013 Q3	$2.88M	Sell	149,729 -887	-0.6%	-$17K	0.01%	569
2013 Q2	$2.68M	Buy	+150,616	New	+$2.72M	0.01%	594

Other funds holding HQL

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Absolute Investment Advisers Rosemary Beach, Florida $1.03B AUM 1% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

RPO LLC Stamford, Connecticut $30.4M AUM 3.41% 1-Year Est. Return

Lazard Asset Management's HQL Position: Q2 2024 in Review

Lazard Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2024, closing a stake of 183,991 shares — an estimated $2.51M sold.

Lazard Asset Management first reported a position in HQL in Q2 2013 and held it in 20 quarters. The position peaked at $4.38M in Q2 2021. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2024.

Lazard Asset Management reported no remaining abrdn Life Sciences Investors position as of Q2 2024 after selling out during the quarter.
Lazard Asset Management sold 183,991 abrdn Life Sciences Investors shares in Q2 2024, an estimated $2.51M.
Lazard Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 20 quarters.
Lazard Asset Management's abrdn Life Sciences Investors position peaked at $4.38M in Q2 2021.
75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2024.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.